Rosca et al., 2005 - Google Patents
Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formationRosca et al., 2005
View HTML- Document ID
- 8557899154022624504
- Author
- Rosca M
- Mustata T
- Kinter M
- Ozdemir A
- Kern T
- Szweda L
- Brownlee M
- Monnier V
- Weiss M
- Publication year
- Publication venue
- American Journal of Physiology-Renal Physiology
External Links
Snippet
Chronic hyperglycemia causes structural alterations of proteins through the Maillard reaction. In diabetes, methylglyoxal (MGO)-induced hydroimidazolones are the predominant modification. In contrast to acute hyperglycemia, mitochondrial respiration is depressed in …
- 206010012601 Diabetes mellitus 0 title abstract description 248
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rosca et al. | Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation | |
Rosca et al. | Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal | |
Fang et al. | The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease | |
Chapple et al. | The role of reactive oxygen and antioxidant species in periodontal tissue destruction. | |
Galino et al. | Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy | |
Beckman | Oxidative damage and tyrosine nitration from peroxynitrite | |
Jakubowski | Molecular basis of homocysteine toxicity in humans | |
Vincent et al. | Oxidative stress in the pathogenesis of diabetic neuropathy | |
Che et al. | Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells: the involvement of reactive oxygen species formation and a possible implication for atherogenesis in diabetes | |
Grassi et al. | Oxidative stress and endothelial dysfunction: say NO to cigarette smoking! | |
Tsai et al. | Antioxidative and anti-inflammatory protection from carnosine in the striatum of MPTP-treated mice | |
Gomez-Quiroz et al. | Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis | |
Andoh et al. | Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin peroxidase-1 during hormesis in response to oxidative stress-induced apoptosis | |
Kedar | Can we prevent Parkinson's and Alzheimer's disease? | |
Fibach et al. | The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia | |
Wu et al. | Nox2-dependent glutathionylation of endothelial NOS leads to uncoupled superoxide production and endothelial barrier dysfunction in acute lung injury | |
Wu et al. | Hepatoprotective effects of salidroside on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice | |
Nakamura et al. | Pivotal role of electrophilicity in glutathione S-transferase induction by tert-butylhydroquinone | |
Hussain et al. | Modifications of proteins by 4-hydroxy-2-nonenal in the ventilatory muscles of rats | |
Ribeiro et al. | Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats | |
Raveendran et al. | Endogenous nitric oxide activation protects against cigarette smoking induced apoptosis in endothelial cells | |
Vasconcelos et al. | Uncovering the role of oxidative imbalance in the development and progression of bronchial asthma | |
Tahirovic et al. | Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer’s disease and diabetes mellitus | |
Hill et al. | Myocardial ischaemia inhibits mitochondrial metabolism of 4-hydroxy-trans-2-nonenal | |
Lagoa et al. | The decrease of NAD (P) H: quinone oxidoreductase 1 activity and increase of ROS production by NADPH oxidases are early biomarkers in doxorubicin cardiotoxicity |